23 . January , 2019 - Wednesday
Check todays hot topics or new products

Find a Drug: Advanced

Please Sign in or Register

All about: Lepirudin

Big Image Pronouncation: (LEP-ih-ruh-din)
Class: Thrombin inhibitor

Trade Names:
Refludan
- Powder for Injection 50 mg

Mechanism of Action

Pharmacology

One molecule of lepirudin (rDNA) binds to 1 molecule of thrombin and blocks the thrombogenic activity of thrombin.

Pharmacokinetics

Distribution

Following IV administration, distribution is confined to extracellular fluids and is characterized by an initial t ½ of approximately 10 min.

Metabolism

Lepirudin is thought to be metabolized by release of amino acids via catabolic hydrolysis.

Elimination

Elimination follows first order kinetics and is characterized by a terminal t ½ of approximately 1.3 h. About 48% of the administered dose is excreted in the urine (35% unchanged).

Special Populations

Renal Function Impairment

In patients with marked renal insufficiency (CrCl less than 15 mL/min) and on hemodialysis, the elimination t ½ is prolonged up to 2 days.

Elderly

Systemic Cl is 20% lower in elderly than in younger patients.

Gender

Systemic Cl is about 25% lower in women than men.

Indications and Usage

Anticoagulation in patients with heparin-induced thrombocytopenia and associated thromboembolic disease to prevent further thromboembolic complications.

Unlabeled Uses

Adjunct therapy for treatment of unstable angina; acute MI without ST elevation; prevention of deep vein thrombosis; patients undergoing percutaneous coronary intervention.

Contraindications

Hypersensitivity to hirudins or any component of the product.

Dosage and Administration

Heparin-Induced Thrombocytopenia
Adults

IV 0.4 mg/kg (up to 110 kg body weight) slowly (eg, over 15 to 20 sec) as a bolus followed by 0.15 mg/kg (up to 110 kg/h of body weight) as a continuous IV infusion for 2 to 10 days or longer if clinically needed.

Dose Modification
Adults

IV If the confirmed APTT ratio is below the target range, increase the infusion rate in steps of 20% and determine the APTT ratio again 4 h later. Do not exceed an infusion rate of 0.21 mg/kg/h without checking for coagulation abnormalities that might prevent an appropriate APTT response. If the confirmed APTT ratio is above the target range, stop the infusion for 2 h. At restart, decrease the infusion 50% and determine the APTT ratio again 4 h later.

Renal Function Impairment
Adults

IV Reduce the dose if there is known or suspected renal function impairment (CrCl less than 60 mL/min or serum creatinine above 1.5 mg/dL). In addition to monitoring renal status, APTT monitoring should be used. In all patients with renal function impairment, the bolus dose is to be reduced to 0.2 mg/kg. Reduce the standard initial infusion rate as follows— CrCl 45 to 60 mL/min or serum creatinine 1.6 to 2 mg/dL— Administer at 50% of the standard infusion rate (0.075 mg/kg/h). CrCl 30 to 44 mL/min or serum creatinine 2.1 to 3 mg/dL— Administer at 30% of the standard infusion rate (0.045 mg/kg/h). CrCl 15 to 29 mL/min or serum creatine 3.1 to 6 mg/dL— Administer at 15% of the standard infusion rate (0.0225 mg/kg/h). Less than 15 mL/min or serum creatine greater than 6 mg/dL— Avoid or stop infusion.

Concomitant Use of Thrombolytic Therapy
Adults

IV Initial bolus of 0.2 mg/kg followed by continuous infusion of 0.1 mg/kg/h.

Switching to Oral Anticoagulants
Adults

Gradually reduce the lepirudin dose to reach an APTT ratio just above 1.5 before initiating oral anticoagulation. Initiate coumarin derivatives only when platelet counts are normalizing. Start maintenance dose with no loading dose. To avoid prothrombotic effects when initiating coumarin, continue parenteral anticoagulation for 4 to 5 days.

General Advice

  • For IV administer only. Not for intradermal, IM, or subcutaneous administration.
  • Follow manufacturer's instructions for reconstitution of powder and dilution of reconstituted solution.
  • Use reconstituted solution immediately. Discard any unused infusion solution after 24 h.
  • Refer to manufacturer's insert for compatibility with IV fluids and other medications.
  • Do not administer if solution is cloudy, discolored, or contains particulate matter.
  • Warm solution to room temperature before administration.
  • Ensure that baseline hematocrit or hemoglobin, platelet count, and APTT ratio (patient APTT over APTT reference value) are performed and evaluated prior to starting therapy.
  • Do not initiate therapy if baseline APTT ratio is 2.5 or more.
  • Ensure that APTT ratio is determined 4 h after start of therapy and after every dosage adjustment, and at least every 24 h thereafter during therapy.
  • Ensure that dosage is adjusted to maintain APTT ratio between 1.5 and 2.5 following manufacturer's recommendations for dosage adjustments.

Storage/Stability

Store unopened vials in refrigerator (36° to 46°F) or at controlled room temperature (59° to 77°F). Reconstituted solution remains stable for up to 24 h at room temperature (eg, during infusion).

Drug Interactions

Coumarin derivatives (eg, vitamin K antagonists), thrombolytics (eg, alteplase, streptokinase)

Risk of bleeding may be increased.

Laboratory Test Interactions

None well documented.

Adverse Reactions

Cardiovascular

Heart failure (2%).

Dermatologic

Bleeding from puncture sites and wounds (11%); allergic skin reactions (4%).

EENT

Epistaxis (4%).

GI

GI and rectal bleeding (5%).

Genitourinary

Hematuria (4%); vaginal bleeding (2%).

Hematologic

Anemia or isolated drop in hemoglobin (12%); sepsis (4%).

Hepatic

Abnormal liver function (5%).

Renal

Abnormal renal function (2%).

Respiratory

Pneumonia (4%).

Miscellaneous

Hematoma or unclassified bleeding (11%); fever, multiorgan failure (4%); unspecified infections (2%); intracranial bleeding; allergic reactions (including cough, bronchospasm, stridor, dyspnea [1% to less than 10%]); anaphylactic reactions (postmarketing).

Precautions

Pregnancy

Category B .

Lactation

Undetermined.

Children

Safety and efficacy not established.

Hypersensitivity

Allergic and hypersensitivity reactions, including anaphylaxis (resulting in shock or death), can occur.

Renal Function

Adjust the dose as indicated.

Hepatic Function

May enhance the anticoagulant effect.

Hemorrhagic events

Hemorrhagic events may occur at any site. Monitor patient for signs of bleeding throughout therapy. If bleeding develops (eg, epistaxis; hematuria; hematemesis; bloody or black, tarry stools) or is suspected (eg, unexplained fall in hematocrit or BP or any unexplained symptoms), notify health care provider immediately.

Intracranial bleeding

Life-threatening intracranial bleeding may occur with coadministration of thrombolytic therapy (eg, alteplase, streptokinase).

Overdosage

Symptoms

Bleeding.

Patient Information

  • Advise patient, family, or caregiver that medication will be prepared and administered by a health care professional in a hospital setting.
  • Instruct patient, family member, or caregiver to report any signs of bleeding or allergic reaction immediately.

Recent Drug Updates at DrugIndexOnline:





Depo-Estradiol Depo-Estradiol
Some commonly used brand names are: In the U.S.— Alora 4 Climara 4 Congest 1 Delestrogen 4 Depo-Estradiol 4 Depogen 4 Estinyl 7 Estrace 4 Estraderm 4 Estragyn 5 5 Estragyn LA 5 4 Estrasorb 4 Estro-L.A. 4 Kestrone-5 5 Neo-Estrone 4 Menest 3 Ogen .625 6 Ogen 1.25 6 Ogen 2.5 6 Ortho-Est .625 more...

Dexamethasone Injection Dexamethasone Injection
Generic Name: Dexamethasone Sodium Phosphate Dosage Form: Injection Dexamethasone Description Dexamethasone sodium phosphate, a synthetic adrenocortical steroid, is a white or slightly yellow crystalline powder. It is freely soluble in water and is more...

Donnagel-PG Donnagel-PG
Some commonly used brand names are: In Canada— Donnagel-PG * Not commercially available in the U.S. Category Antidiarrheal, adsorbent Description Kaolin, pectin, and paregoric (KAY-oh-lin, PEK-tin, and par-e-GOR-ik) combination medicine is used to treat diarrhea. However, it has more...

Dramamine II Dramamine II
Generic Name: meclizine (MEH clih zeen) Brand Names: Antivert, Bonine, Dramamine II, Driminate II What is Dramamine II (meclizine)? Meclizine is an antihistamine. It blocks the effects of the naturally occurring chemical histamine in your body. Meclizine is used to treat nausea, vomitin more...

EC-Naprosyn Enteric-Coated Tablets EC-Naprosyn Enteric-Coated Tablets
Generic Name: Naproxen Enteric-Coated Tablets (na-PROX-en) Brand Name: EC-Naprosyn EC-Naprosyn Enteric-Coated Tablets is a nonsteroidal anti-inflammatory drug (NSAID). It may cause an increased risk of serious and sometimes fatal heart and blood vessel problems (eg, heart attack, stroke). The ri more...

Feverfew Feverfew
Generic Name: Feverfew (Tanacetum parthenium) (Not applicable.) Brand Name: Generics only. No brands available.Feverfew is used for:Migraine headaches, arthritis, menstrual pain, and to reduce fever. It may also have other uses. Check with your pharmacist for more details regarding the particula more...

Herceptin Herceptin
Some commonly used brand names are: In the U.S.— Herceptin In Canada— Herceptin Category Monoclonal antibody antineoplastic Description Trastuzumab (tras-TOO-ze-mab) is a monoclonal antibody. It is used to treat breast cancer that has spread to other parts of the body. Tr more...

Klotrix Klotrix
Generic Name: potassium chloride Dosage Form: Tablets Klotrix Description Klotrix® (potassium chloride) is a solid, oral dosage form of potassium chloride containing 750 mg of potassium chloride, USP (equivalent to 10 mEq of potassium) in a film-coated wax-matrix tablet. This formulation is i more...